Aktuelle Urol 2007; 38(2): 125
DOI: 10.1055/s-2007-959207
Editorial Comment
© Georg Thieme Verlag Stuttgart · New York

Editorial Comment zu:

Brehmer B. u. Mitarb.: Die organerhaltende Nierentumor-TherapieBrehmer B. et al.: Nephron-Sparing Therapy for Renal TumorsP.  Alken
  • 1Klinikum Mannheim, Urologische Universitätsklinik, Mannheim
Further Information

Publication History

Publication Date:
28 March 2007 (online)

P. Alken

Literatur

  • 1 Poppel H van. et al .A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol November 2006
  • 2 Pahernik S. et al . Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.  J Urol. 2006;  175 2027-2031
  • 3 Becker F. et al . Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.  Eur Urol. 2006;  49 308-313
  • 4 Becker F. et al . Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm.  Eur Urol. 2006;  49 1058-1063
  • 5 Campbell S C, Novick A C. Expanding the indications for elective partial nephrectomy: is this advisable?.  Eur Urol. 2006;  49 952-954
  • 6 Siddiqui S A. et al . Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.  J Urol. 2007;  177 59-62
  • 7 Frank I. et al . Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.  J Urol. 2005;  173 1889-1892
  • 8 Frank I. et al . pT2 classification for renal cell carcinoma. Can its accuracy be improved?.  J Urol. 2005;  173 380-384
  • 9 Siemer S. et al . Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.  J Urol. 2005;  173 33-37
  • 10 Roberts W W. et al . Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography.  J Urol. 2005;  173 713-715
  • 11 Bonsib S M. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.  Am J Surg Pathol. 2004;  28 1594-1600

Prof. Dr. med. Peter Alken

Klinikum Mannheim, Urologische Universitätsklinik

Theodor-Kutzer-Ufer 1 - 3

68135 Mannheim

Phone: 0621/383-2229

Fax: 0621/383-3822

Email: peter.alken@uro.ma.uni-heidel.de

    >